Over the years, tremendous efforts have been made by regulators to incentivize pharmaceutical companies to develop medicines specifically for the pediatric population. However, developing drug products for pediatric populations is a challenging undertaking due to the physiological differences between children and adults. This complexity is further compounded with the requirement of age appropriate dosage forms.
Join this webcast to hear a distinguished speaker discuss the current challenges in pediatric drug development programs including predicting oral absorption, and in vitro and in silico methods that can be applied to predict behavior in pediatric populations. During this session, a Catalent expert will highlight formulation and dosage form development strategies based on target product profiles that can help bring patient centric treatments to market faster.
Key Learning Objectives
- Learn about current challenges in predicting oral absorption in pediatric populations
- Explore biorelevant age appropriate in vitro and in silico methods for pediatric drug development
- Discover formulation development strategies and dose form presentation based on target product profiles for pediatric patients
- Understand how dose form manufacturing capabilities are scaled to meet pediatric clinical trial and market requirements
Audience
- Senior/Director New Product Strategy & Development
- Senior/Director Product Development
- Senior/Director R&D
- Formulation Scientists
- Project Leaders/Project Management
- Head/Senior/Director - CMC
- Senior/Director - Strategic Sourcing and Consultants
